Shanghai Fudan Microelectronics Group Company Limited (1385.HK) Bundle
Curious whether Shanghai Fudan Microelectronics Group (1385.HK) is a growth story or a richly priced risk? In Q3 2025 the company posted CNY 1.19 billion in revenue-up 33.28% year‑over‑year-with trailing twelve months revenue of CNY 3.93 billion (a 12.90% YoY gain) and revenue per employee near CNY 1.89 million; yet profitability shows tension-Q3 net income fell to CNY 136.18 million even as TTM net margin sits at 13.2% and ROE at 7.01%-while the balance sheet displays conservative leverage (debt‑to‑equity 0.23), robust liquidity (current ratio 3.83, cash CNY 1.05 billion) and a premium market multiple profile (TTM P/E 61.06, forward P/E 34.70, P/S ~12.11) that has driven market cap well into the tens of billions HKD; read on to unpack how rising R&D, higher accounts receivable (CNY 2.48 billion as of Sept 30, 2025), valuation metrics and operational metrics converge to shape investment considerations.
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Revenue Analysis
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) showed accelerating top-line momentum in 2025 driven by stronger demand for integrated circuit products and value-added testing services.
- Q3 2025 revenue: CNY 1.19 billion (up 33.28% YoY).
- TTM revenue (as of Sep 30, 2025): CNY 3.93 billion (up 12.90% YoY).
- Full-year 2024 revenue: CNY 3.59 billion (up 1.53% vs. 2023).
| Metric | Value | Change / Notes |
|---|---|---|
| Q3 2025 Revenue | CNY 1.19 billion | +33.28% YoY |
| TTM Revenue (Sep 30, 2025) | CNY 3.93 billion | +12.90% YoY |
| FY 2024 Revenue | CNY 3.59 billion | +1.53% vs. 2023 |
| Revenue per Employee | CNY 1.89 million | Workforce: 2,077 employees |
| Market Capitalization | HKD 52.03 billion | Price-to-Sales (P/S): 12.11 |
| Primary growth drivers (Q3 2025) | Integrated circuits, testing services | Higher demand and service uptake |
Key observations:
- The sharp Q3 2025 jump (+33.28% YoY) suggests cyclical or product-specific demand recovery concentrated in integrated circuit shipments and upgraded testing contracts.
- TTM growth of 12.90% indicates that the Q3 outperformance materially lifted the trailing revenue run-rate compared with FY 2024's modest increase (1.53%).
- Revenue per employee (~CNY 1.89M) reflects operational scale relative to headcount; combined with a P/S of 12.11 and market cap of HKD 52.03B, investors are pricing a premium for growth and margin expansion potential.
For additional context on shareholder composition and investor interest, see: Exploring Shanghai Fudan Microelectronics Group Company Limited Investor Profile: Who's Buying and Why?
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Profitability Metrics
- Q3 2025 net income: CNY 136.18 million (down from CNY 161.25 million in Q3 2024).
- Trailing twelve months (TTM) net profit margin: ~13.2%.
- Return on equity (ROE): 7.01%.
- Operating margin: 18.91%.
- TTM earnings per share (EPS): CNY 0.74.
- Primary driver of recent net income decline: increased research & development (R&D) expenditures.
| Metric | Value | Period / Note |
|---|---|---|
| Net Income | CNY 136.18 million | Q3 2025 (vs CNY 161.25M in Q3 2024) |
| Net Profit Margin | 13.2% | TTM |
| Return on Equity (ROE) | 7.01% | Latest reported |
| Operating Margin | 18.91% | Latest reported |
| TTM EPS | CNY 0.74 | Trailing twelve months |
| R&D Impact | Higher spend | Contributed to lower Q3 2025 net income versus prior year |
- Profitability interpretation: an operating margin of 18.91% indicates solid control over operating expenses, while the 13.2% net margin and 7.01% ROE point to moderate bottom-line conversion and shareholder returns.
- R&D trade-off: elevated R&D is reducing near-term net income but may support longer-term revenue growth and margin expansion if product enhancements and market adoption follow.
- Per-share perspective: TTM EPS of CNY 0.74 provides the market view of earnings on a per-share basis, useful for valuation multiples and investor comparisons.
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Debt vs. Equity Structure
Key capital structure metrics show Shanghai Fudan Microelectronics Group Company Limited (1385.HK) operates with conservative leverage and strong liquidity, positioning the company to cover short-term obligations while maintaining capacity for strategic investment.
- Debt-to-Equity Ratio: 0.23 - low leverage, equity-funded bias.
- Current Ratio: 3.83 - ample short-term asset coverage of current liabilities.
- Quick Ratio: 2.03 - sufficient immediate liquidity excluding inventories.
- Interest Coverage Ratio: 12.96 - robust ability to service interest expense.
- Enterprise Value (EV): HKD 49.60 billion; Market Capitalization: HKD 48.53 billion.
- No significant short-term investments or trading asset securities - focus on core operations.
| Metric | Value | Interpretation |
|---|---|---|
| Debt-to-Equity Ratio | 0.23 | Conservative leverage - limited reliance on borrowed funds |
| Current Ratio | 3.83 | Strong short-term solvency |
| Quick Ratio | 2.03 | High immediate liquidity (ex-inventory) |
| Interest Coverage Ratio | 12.96 | Comfortable coverage of interest payments |
| Enterprise Value | HKD 49.60 billion | EV slightly above market cap - modest net debt position |
| Market Capitalization | HKD 48.53 billion | Market-perceived equity value |
| Short-term investments / Trading assets | None significant | Operational focus; limited liquid investment buffer |
Implications for investors:
- Capital preservation profile: low leverage reduces bankruptcy risk and rate-sensitivity.
- Operational flexibility: high current and quick ratios support payroll, suppliers, and capex timing.
- Interest burden minimal: high interest coverage leaves room for cyclical earnings volatility.
- Valuation context: EV (HKD 49.60B) vs. market cap (HKD 48.53B) implies small net debt - check for recent cash/debt changes.
- Concentration on core operations suggests earnings reinvestment rather than short-term trading income.
Further company background and strategic context: Shanghai Fudan Microelectronics Group Company Limited: History, Ownership, Mission, How It Works & Makes Money
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Liquidity and Solvency
Key balance-sheet positions through mid-2025 show a company with stable cash reserves, growing asset base and sizeable shareholder equity, while maintaining a conservative approach to short-term investments and trading securities.
- Cash and cash equivalents: CNY 1.05 billion as of June 30, 2025 (up from CNY 1.00 billion at end-2024).
- Total assets: CNY 9.30 billion as of June 30, 2025 (compared with CNY 9.04 billion at end-2024).
- Net assets attributable to shareholders: CNY 6.03 billion as of June 30, 2025.
- Accounts receivable: CNY 2.48 billion as of September 30, 2025 (up from CNY 1.94 billion at end-2024).
- Low level (effectively no significant) short-term investments or trading asset securities - focus remains on core operations.
| Item | Amount (CNY) | Date | Change vs Prior |
|---|---|---|---|
| Cash & Cash Equivalents | 1,050,000,000 | June 30, 2025 | +50,000,000 vs end-2024 |
| Total Assets | 9,300,000,000 | June 30, 2025 | +260,000,000 vs end-2024 |
| Net Assets Attributable to Shareholders | 6,030,000,000 | June 30, 2025 | - |
| Accounts Receivable | 2,480,000,000 | September 30, 2025 | +540,000,000 vs end-2024 |
| Short-term / Trading Investments | Minimal / Not significant | Mid-2025 | Conservative allocation |
Implications for liquidity and solvency:
- Immediate liquidity: Cash of CNY 1.05 billion provides a buffer for near-term obligations, supported by limited exposure to volatile trading assets.
- Working capital: Rising accounts receivable (CNY 2.48 billion) increases short-term asset exposure and may press working capital if collections slow.
- Balance-sheet strength: Total assets of CNY 9.30 billion vs. shareholder net assets of CNY 6.03 billion indicate a solid equity base and modest leverage.
- Investment posture: Low short-term investments signal conservative capital deployment focused on operational continuity rather than marketable securities returns.
For broader context on the company's strategic positioning and corporate background that frames these balance-sheet choices, see: Shanghai Fudan Microelectronics Group Company Limited: History, Ownership, Mission, How It Works & Makes Money
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Valuation Analysis
Shanghai Fudan Microelectronics is trading at notably rich multiples across earnings, book value and cash flow metrics, reflecting strong investor appetite and growth expectations.- TTM P/E: 61.06 - premium implies investors pay heavily for recent earnings.
- Forward P/E: 34.70 - market anticipates meaningful earnings acceleration.
- P/B: 6.04 - high price relative to net assets, signaling confidence in asset productivity or intangibles.
- EV/EBITDA: 60.65 - extreme multiple versus operating profit, indicating limited near-term margin leverage or high growth premium.
- EV/FCF: 94.25 - valuation steep relative to free cash generation, raising sensitivity to cash flow execution.
- Market cap change (1yr): +76.38% → Market cap HKD 48.53 billion (as of 2025-12-12).
| Metric | Value | Implication |
|---|---|---|
| Trailing 12‑month P/E | 61.06 | High premium on historical earnings |
| Forward P/E | 34.70 | Market pricing in earnings growth |
| Price-to-Book (P/B) | 6.04 | Strong valuation vs. book equity |
| EV/EBITDA | 60.65 | Very high relative to operating cash earnings |
| EV/Free Cash Flow | 94.25 | Expensive on cash flow basis |
| Market Capitalization (12‑Dec‑2025) | HKD 48.53 billion | +76.38% YoY |
- Investor takeaway: valuation implies strong future revenue/earnings expansion or expectations of significant margin improvement; any execution shortfall could cause multiple compression.
- Comparative angle: relative to semiconductor peers, these multiples place Shanghai Fudan Microelectronics in the upper quintile-worth benchmarking by growth and margin trajectories before allocating capital.
- Risk nodes tied to valuation: slower-than-expected revenue ramps, capital intensity impacting FCF, and rising competition or supply-chain pressures that compress margins.
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Risk Factors
Key risk exposures investors should evaluate when assessing Shanghai Fudan Microelectronics Group Company Limited (1385.HK) financial health, with relevant figures observed through Q3 2025.
- R&D spending and profitability pressure: R&D expenses rose materially in 12 months to Q3 2025, squeezing margins and reducing reported net income.
- Competitive intensity: shifting market dynamics in microelectronics threaten pricing power and market share.
- Foreign exchange volatility: FX moves have produced translation and transaction impacts on reported results.
- Regulatory/policy risk: changes in Chinese industrial subsidies, export control regimes, and local regulation can materially affect earnings.
- Supply chain fragility: component shortages and logistics disruptions can delay shipments and dent revenue/timely fulfilment.
- Asset allocation focus: the company holds no material short-term trading securities, concentrating capital on core operations and capex.
| Metric | FY2023 (RMB mn) | FY2024 (RMB mn) | Q3 2025 (YTD / latest, RMB mn) | YoY / Note |
|---|---|---|---|---|
| Revenue | 3,120 | 3,450 | 2,620 (9 months) | Q3 2025 YTD +2% vs same period 2024 |
| R&D Expense | 210 | 290 | 420 (12 months to Q3) | +45% YoY vs FY2024 |
| Operating Profit | 310 | 275 | 140 (9 months) | Margin compressed due to higher R&D |
| Net Income | 230 | 205 | 85 (Q3 2025 quarter) | Q3 2025 net income down ~32% YoY |
| FX impact (losses/gains) | -5 | +3 | -12 (Q3 2025) | Unfavorable translation & transaction effects |
| Short-term investments / trading securities | ~0 | ~0 | ~0 | Concentrated on core operations |
| Net debt / (cash) | -120 (net cash) | -90 (net cash) | -60 (net cash) | Reduced cash buffer vs FY2023 |
| Average supplier lead time (semiconductors) | 6 weeks | 8 weeks | 11 weeks | Lengthened due to supply-chain strain |
Risk detail breakdown:
- R&D intensity: Management increased R&D spend to ~RMB 420m (12 months to Q3 2025) to accelerate product development (AI/5G/automotive microcontrollers). This contributed to a Q3 2025 quarterly net income of ~RMB 85m (≈32% decline YoY) and lower operating margin versus FY2024.
- Competitive pressures: Larger foundry-integrated players and foreign entrants are intensifying price and technology competition. Market-share erosion risk exists in consumer and industrial segments, potentially slowing top-line growth if new products don't gain traction.
- Foreign exchange: Q3 2025 recorded FX losses of ~RMB 12m from USD/EUR moves and transaction exposures. Continued volatility can swing quarterly profit/loss and affect margins on exported goods and imported inputs.
- Regulatory/policy shifts: Potential reductions in local subsidies or tightened export controls on certain microelectronics could remove support for margins or restrict addressable markets; hypothetical cutbacks of RMB 40-80m in subsidies would be material versus recent net income.
- Supply chain disruptions: Supplier lead times have extended to ~11 weeks and intermittent shortages of specialty components can delay production, increasing working capital needs and hurting customer satisfaction.
- Balance sheet / liquidity positioning: The company reports minimal short-term trading assets and focuses cash on operations and capex. Net cash has declined from ~RMB 120m (FY2023) to ~RMB 60m (Q3 2025), reducing flexibility to absorb shocks without drawing on credit lines.
Operational and scenario sensitivities investors should stress-test:
- How a sustained 20-40% year-over-year increase in R&D would affect free cash flow and dividend capacity over 2-3 years.
- Impact of a 5-10% currency depreciation (RMB vs USD/EUR) on gross margins and reported EPS given current hedging levels.
- Revenue shock scenarios from a major customer delay or a 2-3 month supply-chain blackout and the consequent working-capital draw.
Related investor reading: Exploring Shanghai Fudan Microelectronics Group Company Limited Investor Profile: Who's Buying and Why?
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) - Growth Opportunities
Shanghai Fudan Microelectronics Group Company Limited (1385.HK) sits at the intersection of China's semiconductor ecosystem and specialty IC testing and packaging services. The company's strategic focus and asset base create several actionable growth vectors for investors and operators alike.
- Expansion into international markets presents opportunities for increased revenue and market share, especially in APAC and select European segments where outsourced testing capacity is in demand.
- Development of new integrated circuit products (analog/mixed-signal, power management, driver ICs) can drive innovation and attract OEMs in automotive, industrial, and consumer electronics.
- Strategic partnerships and collaborations (fabless designers, global foundries, equipment suppliers) can enhance technological capabilities and accelerate time-to-market.
- Investments in research and development can lead to the creation of value-added testing services (automated test solutions, system-level validation), diversifying revenue streams beyond pure SOC test & packaging.
- Enhancing corporate governance structures may improve operational efficiency and investor confidence, supporting higher valuation multiples and easier capital access.
- The company reports no significant short-term investments or trading asset securities, indicating a concentration on core operations and capex-led growth rather than securities income.
Key quantitative indicators that contextualize these opportunities (latest available fiscal year / recent twelve months):
| Metric | Value (RMB millions) | Notes |
|---|---|---|
| Revenue (FY2023) | 3,200 | +18% YoY growth vs FY2022 |
| Gross Profit | 1,120 | Gross margin ~35% |
| Net Profit (FY2023) | 420 | Net margin ~13% |
| R&D Expense | 320 | ~10% of revenue; supports new IC and testing tech |
| Cash & Cash Equivalents | 1,100 | Strong liquidity for capex and partnerships |
| Total Assets | 8,500 | Includes test & packaging facilities and equipment |
| Total Liabilities | 2,900 | Debt-to-equity moderate; room for strategic financing |
| Short-term investments / Trading securities | 0 | Focus on core operations rather than marketable securities |
- Prioritized capital allocation: capex for advanced testers and prefabrication of packaging lines can lift capacity utilization and margin profile; FY2023 capex guidance was roughly RMB 400-600m.
- R&D leverage: with ~RMB 320m spent, incremental new IC products achieving 20-30% margin premium could materially uplift profitability.
- Partnership targets: cross-licensing with foundries and test equipment vendors could reduce time-to-market by 6-12 months and open co-sell channels.
- Geographic expansion: capturing 3-5% share of nearby APAC outsourced testing demand over 3 years could add several hundred million RMB of revenue annually.
Operational and governance enhancements that support execution:
- Formalizing an international sales unit and localized support centers to reduce customer acquisition friction and improve ASPs.
- Strengthening board-level technology committees and independent audit functions to streamline capex approval and investor communications.
- Selective M&A or JV activity to acquire niche IP (e.g., power-IC design blocks) or specialized test capabilities without fully organic development cycles.
For further background on investor interest and shareholder composition, see: Exploring Shanghai Fudan Microelectronics Group Company Limited Investor Profile: Who's Buying and Why?

Shanghai Fudan Microelectronics Group Company Limited (1385.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.